Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global 3D Printing in Pharmaceutical market size was valued at USD 70 million in 2022 and is forecast to a readjusted size of USD 115.8 million by 2029 with a CAGR of 7.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The traditional pharmaceutical process is complicated, while the 3D printing of drugs has the characteristics of "rapid prototyping" and the production process is simple. And the production equipment required for 3D printing drugs is much smaller than traditional pharmaceutical equipment, which can realize on-demand production, which has significant advantages in large-scale and small-scale drug production.
This report is a detailed and comprehensive analysis for global 3D Printing in Pharmaceutical market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
The Primary Objectives in This Report Are:
This report profiles key players in the global 3D Printing in Pharmaceutical market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aprecia Pharmaceuticals, Triastek, FabRx, Multiply Labs and Craft Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
3D Printing in Pharmaceutical market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Market segment by Application
Market segment by players, this report covers
Market segment by regions, regional analysis covers
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe 3D Printing in Pharmaceutical product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of 3D Printing in Pharmaceutical, with revenue, gross margin and global market share of 3D Printing in Pharmaceutical from 2018 to 2023.
Chapter 3, the 3D Printing in Pharmaceutical competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and 3D Printing in Pharmaceutical market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of 3D Printing in Pharmaceutical.
Chapter 13, to describe 3D Printing in Pharmaceutical research findings and conclusion.
Index
1 Market Overview
1.1 Product Overview and Scope of 3D Printing in Pharmaceutical
1.2 Market Estimation Caveats and Base Year
1.3 Classification of 3D Printing in Pharmaceutical by Type
1.3.1 Overview: Global 3D Printing in Pharmaceutical Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global 3D Printing in Pharmaceutical Consumption Value Market Share by Type in 2022
1.3.3 Material Extrusion
1.3.4 Binder Jetting
1.3.5 Powder Bed Fusion
1.3.6 VAT Photopolymerization
1.3.7 Other
1.4 Global 3D Printing in Pharmaceutical Market by Application
1.4.1 Overview: Global 3D Printing in Pharmaceutical Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Mass Production
1.4.3 Personalized Medicine
1.5 Global 3D Printing in Pharmaceutical Market Size & Forecast
1.6 Global 3D Printing in Pharmaceutical Market Size and Forecast by Region
1.6.1 Global 3D Printing in Pharmaceutical Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global 3D Printing in Pharmaceutical Market Size by Region, (2018-2029)
1.6.3 North America 3D Printing in Pharmaceutical Market Size and Prospect (2018-2029)
1.6.4 Europe 3D Printing in Pharmaceutical Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific 3D Printing in Pharmaceutical Market Size and Prospect (2018-2029)
1.6.6 South America 3D Printing in Pharmaceutical Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa 3D Printing in Pharmaceutical Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Aprecia Pharmaceuticals
2.1.1 Aprecia Pharmaceuticals Details
2.1.2 Aprecia Pharmaceuticals Major Business
2.1.3 Aprecia Pharmaceuticals 3D Printing in Pharmaceutical Product and Solutions
2.1.4 Aprecia Pharmaceuticals 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Aprecia Pharmaceuticals Recent Developments and Future Plans
2.2 Triastek
2.2.1 Triastek Details
2.2.2 Triastek Major Business
2.2.3 Triastek 3D Printing in Pharmaceutical Product and Solutions
2.2.4 Triastek 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Triastek Recent Developments and Future Plans
2.3 FabRx
2.3.1 FabRx Details
2.3.2 FabRx Major Business
2.3.3 FabRx 3D Printing in Pharmaceutical Product and Solutions
2.3.4 FabRx 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 FabRx Recent Developments and Future Plans
2.4 Multiply Labs
2.4.1 Multiply Labs Details
2.4.2 Multiply Labs Major Business
2.4.3 Multiply Labs 3D Printing in Pharmaceutical Product and Solutions
2.4.4 Multiply Labs 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Multiply Labs Recent Developments and Future Plans
2.5 Craft Health
2.5.1 Craft Health Details
2.5.2 Craft Health Major Business
2.5.3 Craft Health 3D Printing in Pharmaceutical Product and Solutions
2.5.4 Craft Health 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Craft Health Recent Developments and Future Plans
2.6 DiHeSys
2.6.1 DiHeSys Details
2.6.2 DiHeSys Major Business
2.6.3 DiHeSys 3D Printing in Pharmaceutical Product and Solutions
2.6.4 DiHeSys 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 DiHeSys Recent Developments and Future Plans
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck 3D Printing in Pharmaceutical Product and Solutions
2.7.4 Merck 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck Recent Developments and Future Plans
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca 3D Printing in Pharmaceutical Product and Solutions
2.8.4 AstraZeneca 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AstraZeneca Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global 3D Printing in Pharmaceutical Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of 3D Printing in Pharmaceutical by Company Revenue
3.2.2 Top 3 3D Printing in Pharmaceutical Players Market Share in 2022
3.2.3 Top 6 3D Printing in Pharmaceutical Players Market Share in 2022
3.3 3D Printing in Pharmaceutical Market: Overall Company Footprint Analysis
3.3.1 3D Printing in Pharmaceutical Market: Region Footprint
3.3.2 3D Printing in Pharmaceutical Market: Company Product Type Footprint
3.3.3 3D Printing in Pharmaceutical Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global 3D Printing in Pharmaceutical Consumption Value and Market Share by Type (2018-2023)
4.2 Global 3D Printing in Pharmaceutical Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global 3D Printing in Pharmaceutical Consumption Value Market Share by Application (2018-2023)
5.2 Global 3D Printing in Pharmaceutical Market Forecast by Application (2024-2029)
6 North America
6.1 North America 3D Printing in Pharmaceutical Consumption Value by Type (2018-2029)
6.2 North America 3D Printing in Pharmaceutical Consumption Value by Application (2018-2029)
6.3 North America 3D Printing in Pharmaceutical Market Size by Country
6.3.1 North America 3D Printing in Pharmaceutical Consumption Value by Country (2018-2029)
6.3.2 United States 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
6.3.3 Canada 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
6.3.4 Mexico 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe 3D Printing in Pharmaceutical Consumption Value by Type (2018-2029)
7.2 Europe 3D Printing in Pharmaceutical Consumption Value by Application (2018-2029)
7.3 Europe 3D Printing in Pharmaceutical Market Size by Country
7.3.1 Europe 3D Printing in Pharmaceutical Consumption Value by Country (2018-2029)
7.3.2 Germany 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
7.3.3 France 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
7.3.4 United Kingdom 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
7.3.5 Russia 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
7.3.6 Italy 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific 3D Printing in Pharmaceutical Consumption Value by Type (2018-2029)
8.2 Asia-Pacific 3D Printing in Pharmaceutical Consumption Value by Application (2018-2029)
8.3 Asia-Pacific 3D Printing in Pharmaceutical Market Size by Region
8.3.1 Asia-Pacific 3D Printing in Pharmaceutical Consumption Value by Region (2018-2029)
8.3.2 China 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
8.3.3 Japan 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
8.3.4 South Korea 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
8.3.5 India 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
8.3.7 Australia 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
9 South America
9.1 South America 3D Printing in Pharmaceutical Consumption Value by Type (2018-2029)
9.2 South America 3D Printing in Pharmaceutical Consumption Value by Application (2018-2029)
9.3 South America 3D Printing in Pharmaceutical Market Size by Country
9.3.1 South America 3D Printing in Pharmaceutical Consumption Value by Country (2018-2029)
9.3.2 Brazil 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
9.3.3 Argentina 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa 3D Printing in Pharmaceutical Consumption Value by Type (2018-2029)
10.2 Middle East & Africa 3D Printing in Pharmaceutical Consumption Value by Application (2018-2029)
10.3 Middle East & Africa 3D Printing in Pharmaceutical Market Size by Country
10.3.1 Middle East & Africa 3D Printing in Pharmaceutical Consumption Value by Country (2018-2029)
10.3.2 Turkey 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
10.3.4 UAE 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 3D Printing in Pharmaceutical Market Drivers
11.2 3D Printing in Pharmaceutical Market Restraints
11.3 3D Printing in Pharmaceutical Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 3D Printing in Pharmaceutical Industry Chain
12.2 3D Printing in Pharmaceutical Upstream Analysis
12.3 3D Printing in Pharmaceutical Midstream Analysis
12.4 3D Printing in Pharmaceutical Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Published By : GlobalInfoResearch